Mediark
Cheongju
About Mediark
Mediark possesses innovative porous material technology and develops innovative products in the chemical/biotechnology fields through this. In addition to nano/micro particle size control, we are developing adsorbents, catalysts, vaccines, targeted therapeutics, and synthetic drugs through pore control/surface modification/drug loading technology and are striving to commercialize them.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Jan 2025)
- Website: mediark.kr
- Phone: 043-715-3690
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/mediark-3260687 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.